Emergent BioSolutions Inc (NYSE:EBS)

53.13
BATS BZX Real-Time Price
As of 10:37am ET
 -0.50 / -0.93%
Today’s Change
32.35
Today|||52-Week Range
55.94
+14.33%
Year-to-Date
No recent news for Emergent BioSolutions Inc.

Today’s Trading

Previous close53.63
Today’s open53.65
Day’s range52.68 - 53.65
Volume2,409
Average volume (3 months)337,232
Market cap$2.5B
Data as of 10:37am ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)+51.33%
Earnings growth (this year)+26.49%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.75%
P/E ratio38.2
Price/Sales4.17
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...-5.97-15.01%
LXRXLexicon Pharmaceutic...-0.31-2.26%
INVAInnoviva Inc-0.19-1.25%
MYOKMyoKardia Inc-0.80-1.63%
Data as of 10:41am ET, 06/21/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)$0.89
Annual revenue (last year)$560.9M
Annual profit (last year)$82.6M
Net profit margin14.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
President &
Chief Operating Officer
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts